Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Lymphoma, Lymphoma Research, Lymphoma treatment, Diffuse large B-cell lymphoma, Clinical Trial, Clinical Trial participation, oral cancer drugs

UNMC Seeking Lymphoma Patients for Oral Two-Drug Study

green-lunning.jpg

Most cancer treatments come in the form of chemotherapy given intravenously. This is unique because it uses a combination of two oral medications.

Medicine

Channels:

Less Satisfaction in Breast Cancer Patients Who Have Radiation and Implants, Personalized Cancer Vaccine for AML, Model to Predict if Chemotherapy Will Work for Aggressive Breast Cancer, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

Medicine

Science

Channels:

Antibiotic Resistance, scientist profile, Profile, Microbiome, Drug Resistant Bacteria, Gut commensal microbiota

The Irresistible Resistome: How Infant Diapers Might Help Combat Antibiotic Resistance (Sort of)

Picture2.png

Biochemist Gautam Dantas inspects what’s deposited on infant diapers for clues about antibiotic resistance.

Medicine

Channels:

Personaized Medicine, drug cocktails, Drug Combinations, Modeling, Cancer Treatment, Alon

How to Mix the Perfect (Drug) Cocktail

The fine art of mixing drug cocktails is incredibly complicated, with virtually infinite numbers of possible interactions and side effects. Now, a new model from the Weizmann Institute lab of Prof. Uri Alon lets scientists compare combinations of drugs to determine efficacy – a major step forward in personalized medicine.

Medicine

Channels:

Parkinson Disease, Parkinson Disease Treatment

Diabetes Drug Slows Experimental Parkinson’s Disease Progression, Human Trials to Begin Next Year

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of Parkinson’s disease following publication of research findings today in the journal Science Translational Medicine.

Medicine

Channels:

ASH Conference, Ash, American Society Of Hematology, Lymphoma, Acute Myeloid Leukemia, AML, hypomethylation, Yale Cancer Center

Alternative Option to Intensive Chemotherapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

ASH.jpg

A Yale Cancer Center team has evaluated the use of hypomethylating agents in patients suffering from Acute Myeloid Leukemia (AML) who were resistant to treatment with intensive chemotherapy.

Science

Channels:

Bethlehem Star May Not Be a Star After All, The "Eye" of Majoranas, Cloud in a Box, and MORE in the Physics News Source Sponsored by AIP

Click here to go directly to the Physics News Source Sponsored by AIP.

Science

Channels:

Gates Foundation, Grant Award, Taste, pharmaceutical compliance, Children, Bitter Taste Sensitivity, parasitic infections, Schistosomiasis, recurrent diarrhea, sensory science, taste cells, screening assays, develolping nations, Pharmaceuticals, Interdisciplinary Research, taste blockers

Monell Center Receives Funding to Develop Technologies to Improve Taste of Lifesaving Drugs

Gatesteam.jpg

The Monell Center announced today that it has received a $345,000 grant from the Bill & Melinda Gates Foundation. The grant supports an innovative global health research project titled, "Developing Novel Pediatric Formulation Technologies for Global Health: Human Taste Assays."

Medicine

Channels:

Chemotherapy, Taxane, Bevacizumab, Maintenance Therapy, Metastatic Breast Cancer, HER2 Negative, Survival Rate, progression-free survival

Treatment Combination to Improve Survival in HER2-Negative Metastatic Breast Cancer

The study, “A Real-World Multicentre Retrospective Observational Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line Treatment for HER2-Negative Metastatic Breast Cancer,” was recently published in the Journal of Cell Physiology.

Medicine

Channels:

Scripps Florida Scientists Create Innovative Drug Design Strategy to Improve Breast Cancer Treatment

nettles_kendall.jpg

A new study by scientists from the Florida campus of The Scripps Research Institute (TSRI) offers a novel structure-based drug design strategy aimed at altering the basic landscape of this type of breast cancer treatment.

Medicine

Channels:

Cancer, Precision Medicine, Personalized Medicine, molecular tumor board, Genetic Testing

Expanding Precision Medicine Options, UK Markey Cancer Center Launches Molecular Tumor Board

161011JILLKOLESAR-MC235.JPG

The University of Kentucky Markey Cancer Center recently launched its own Molecular Tumor Board, an approach to cancer care that uses genetic analysis to help oncologists choose cancer therapies tailored to each patient's individual needs. The Molecular Tumor Board is the latest precision medicine initiative to come online at Markey.

Medicine

Channels:

Osteoporosis, NYU Dentistry, New York University College of Dentistry, National Institute of Diabetes and Digestive Kidney Diseases, Research Grant

NYU College of Dentistry’s Dr. Nicola Partridge Awarded $1.9 M to Further Osteoporosis Drug Research and Development

The federally funded grant will support bench research aimed at understanding how the protein hormone, parathyroid hormone-a related protein-and a drug analog that mimics the protein called abaloparatide, interact in the surface of a cell in bone and affect bone formation and breakdown.

Medicine

Channels:

Purdue Pharma, The University of Texas Health Science Center at Houston (UTHealth), Michael Blackburn, Bruce D. Butler, Drug Development

UTHealth, Purdue Pharma Enter Long-Term Research & Education Alliance

UTHealth and Purdue Pharma L.P. have entered into a specialized alliance to bring academic researchers and drug developers closer together with the common goals of accelerating the development of new drug therapies for patients while advancing the science and providing unique educational experiences for both.

Medicine

Channels:

Genome, Genome Sequence, Precision Medicine, Precision Medicine Initiative, Governor Brown, CHORI

UCSF Benioff Children’s Hospital Oakland Research Institute and Partners to Receive $1.2 Million Grant from California Initiative to Advance Precision Medicine

A team at the Oakland and San Francisco campuses of UCSF Benioff Children’s Hospitals, UCSF, and UC Berkeley have been awarded $1.2 million by California Initiative to Advance Precision Medicine (CIAPM) to help advance precision medicine in the state.

Medicine

Channels:

Organized Prescription Drug Collection Programs May Have Minimal Impact on Reducing Availability of Controlled Medications

More than 3.8 billion controlled medications, such as hydrocodone, oxycodone, Valium and Adderall, are dispensed by pharmacies annually in the United States. It has been estimated that only about 30 percent of these drugs are used by the people for whom they were prescribed. The remaining 70 percent represent a large surplus of controlled medications that could be abused or sold to others for abuse.

Medicine

Channels:

X-ray Crystallogaphy, Medicine, Solid State, Chemistry, Dosage, Cancer, rare disease, Antiviral Drugs, Global Health, pediatric diseases

AAPS Announces Dale E. Wurster Award in Pharmaceutics

The American Association of Pharmaceutical Scientists is pleased to announce the 2016 Dale E. Wurster recipient, Stephen R. Byrn, Ph.D., of Purdue University. Byrn is recognized for his work in the field of Solid State Chemistry of Drugs. Supported by the Dale E. Wurster Endowment, this award is given to individuals who have made significant contributions to the pharmaceutical sciences in the specific field of pharmaceutics.

Medicine

Channels:

Biologics, Personalized Medicine, polymyalgia rheumatica, Precision Medicine, Rheumatoid Arthritis, Sarcoidosis, Vasculitis

Mayo Clinic Research Sheds Light on Why Some Rheumatoid Arthritis Patients Respond Poorly to Biologics

A Mayo Clinic study is shedding light on why some rheumatoid arthritis patients respond poorly when treated with tumor necrosis factor inhibitors, part of a class of drugs called biologics.

Medicine

Channels:

CDC, Antibiotic, Antibiotic Resistant Infections, Resistant Bacteria, Drug Resistant Bacteria, Infection

Let’s “Get Smart About Antibiotics” Week

mrsa.jpg

The discovery of antibiotics remains one of the most important medical advances to date, but overuse and inappropriate use of antibiotics has led to many infections becoming resistant to treatment.

Medicine

Channels:

Celebrex, Celecoxib, Lexapro, Depression, inflammation and depression, Bipolar Disorder

Arthritis Drug Boosts Effectiveness of Antidepressant Medication

Giving severely depressed patients the arthritis drug celecoxib (Celebrex®) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.

Medicine

Channels:

genes, Genome, Health, Biochemistry, Personalized Medicine, DNA, Medicine

First Cellular Atlas of DNA-Binding Molecule Could Advance Precision Therapies

PNASresearchimagecropped.png

Biochemists at the University of Wisconsin–Madison have created the first atlas that maps where molecular tools that can switch genes on and off will bind to the human genome. It is a development they say could enable these tools to be targeted to specific parts of an individual’s genome for use in precision medicine, developing therapies and treating disease.







Chat now!